Doubts about Kazakhstan's single drug distributor remain
This article was originally published in Scrip
Kazakhstan's health ministry hopes that the establishment of a single public-private company for purchasing and distributing pharmaceuticals for guaranteed free medical services will improve availability for patients and help to curb price growth. The new distributor was scheduled to become operational on July 1st, but the industry is unsure if it will.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.